These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 19422592)
1. Use of triple-site ventricular pacing in a patient with severe congestive heart failure and atrial fibrillation. Osman F; Jeilan M; Ng GA Pacing Clin Electrophysiol; 2009 May; 32(5):673-4. PubMed ID: 19422592 [TBL] [Abstract][Full Text] [Related]
2. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure. Delnoy PP; Ottervanger JP; Luttikhuis HO; Elvan A; Misier AR; Beukema WP; van Hemel NM Am J Cardiol; 2007 May; 99(9):1252-7. PubMed ID: 17478153 [TBL] [Abstract][Full Text] [Related]
3. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial. Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G; Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135 [TBL] [Abstract][Full Text] [Related]
4. A randomized comparison of triple-site versus dual-site ventricular stimulation in patients with congestive heart failure. Leclercq C; Gadler F; Kranig W; Ellery S; Gras D; Lazarus A; Clémenty J; Boulogne E; Daubert JC; J Am Coll Cardiol; 2008 Apr; 51(15):1455-62. PubMed ID: 18402900 [TBL] [Abstract][Full Text] [Related]
5. Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure. Hoppe UC; Casares JM; Eiskjaer H; Hagemann A; Cleland JG; Freemantle N; Erdmann E Circulation; 2006 Jul; 114(1):18-25. PubMed ID: 16801461 [TBL] [Abstract][Full Text] [Related]
9. Atrioventricular node ablation is not a prerequisite for cardiac resynchronization therapy in patients with chronic atrial fibrillation. Schütte F; Lüdorff G; Grove R; Kranig W; Thale J Cardiol J; 2009; 16(3):246-9. PubMed ID: 19437399 [TBL] [Abstract][Full Text] [Related]
10. Is coronary vein angioplasty necessary to provide cardiac resynchronization in selected patients? A case report. Sterliński M; Sosnowski C; Zajac D; Ruzyłło W; Szwed H Europace; 2008 Sep; 10(9):1116-8. PubMed ID: 18519447 [TBL] [Abstract][Full Text] [Related]
11. Comparison of benefits and mortality in cardiac resynchronization therapy in patients with atrial fibrillation versus patients in sinus rhythm (Results of the Spanish Atrial Fibrillation and Resynchronization [SPARE] Study). Tolosana JM; Hernandez Madrid A; Brugada J; Sitges M; Garcia Bolao I; Fernandez Lozano I; Martinez Ferrer J; Quesada A; Macias A; Marin W; Escudier JM; Gomez AA; Gimenez Alcala M; Tamborero D; Berruezo A; Mont L; Am J Cardiol; 2008 Aug; 102(4):444-9. PubMed ID: 18678303 [TBL] [Abstract][Full Text] [Related]
12. Sinus rhythm restoration by catheter ablation in patients with long-lasting atrial fibrillation and congestive heart failure: impact of the left ventricular ejection fraction improvement on the implantable cardioverter defibrillator insertion indication. Bortone A; Boveda S; Pasquié JL; Pujadas-Berthault P; Marijon E; Appetiti A; Albenque JP Europace; 2009 Aug; 11(8):1018-23. PubMed ID: 19556251 [TBL] [Abstract][Full Text] [Related]
14. Cardiac resynchronization therapy in the setting of permanent atrial fibrillation and heart failure. Koneru JN; Steinberg JS Curr Opin Cardiol; 2008 Jan; 23(1):9-15. PubMed ID: 18281821 [TBL] [Abstract][Full Text] [Related]
15. Atrial fibrillation therapy in patients with a CRT defibrillator with wireless telemetry. Crossley GH; Aonuma K; Haffajee C; Shoda M; Meijer A; Bauer A; Boriani G; Svendsen J; Thomas S; Wiggenhorn C; Unterberg-Buchwald C; Pacing Clin Electrophysiol; 2009 Jan; 32(1):13-23. PubMed ID: 19140908 [TBL] [Abstract][Full Text] [Related]
16. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C; J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193 [TBL] [Abstract][Full Text] [Related]
17. Omega-3 polyunsaturated fatty acids prevent atrial fibrillation associated with heart failure but not atrial tachycardia remodeling. Sakabe M; Shiroshita-Takeshita A; Maguy A; Dumesnil C; Nigam A; Leung TK; Nattel S Circulation; 2007 Nov; 116(19):2101-9. PubMed ID: 17967774 [TBL] [Abstract][Full Text] [Related]
18. Cardiac resynchronization therapy in heart failure patients: an update. Jeevanantham V; Daubert JP; Zareba W Cardiol J; 2009; 16(3):197-209. PubMed ID: 19437393 [TBL] [Abstract][Full Text] [Related]
19. [Atrio-biventricular electrostimulation in the treatment of congestive heart failure. Case report]. Bencić ML; Milicić D; Kosi D; Gras D; Ferek-Petrić B; Buljević B; Goldner V Lijec Vjesn; 2000; 122(5-6):127-31. PubMed ID: 11040534 [TBL] [Abstract][Full Text] [Related]
20. Cardiac resynchronization therapy in patients with heart failure and atrial fibrillation: importance of new-onset atrial fibrillation and total atrial conduction time. Buck S; Rienstra M; Maass AH; Nieuwland W; Van Veldhuisen DJ; Van Gelder IC Europace; 2008 May; 10(5):558-65. PubMed ID: 18356205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]